CD8A and cancer: Intratumoral CD8+ CTLs in cancers of colorectal [15], [16], lung [17], [18], oesophageal [19], [20], epithelial ovarian [21], [22], renal cell [23] and pancreatic cancers [24] were believed to have protectively prognostic effect.